Experimental Leishmania major infection suppresses HIV-1 DNA vaccine induced cellular immune response

Cells Tissues Organs. 2004;177(3):185-8. doi: 10.1159/000079992.

Abstract

The AIDS epidemic in the developing world represents a major global crisis and an effective vaccine is imperative. However, many parasites are common in developing countries and can result in a state of chronic immune activation that is polarized towards a Th2 profile and which can potentially impair responses to vaccines or other infectious challenges. In this study we demonstrate that experimental Leishmania major infection of BALB/c mice inhibits responses to a DNA-based HIV-1 gag vaccine. L. major infection in BALB/c results in a polarized Th2 immune response. In this study naïve BALB/c mice immunized with the HIV-1 gag DNA vaccine mounted a cellular immune response against the vaccine antigen, HIV-1 gag. CD8+ T lymphocytes were able to respond in vitro to HIV-1 gag stimulation and secrete interferon (IFN)-gamma. However, L. major-infected, vaccinated BALB/c mice had a significantly reduced number of IFN-gamma-producing CD8+ T cells following in vitro stimulation with gag antigen. These data suggest that parasitic infection, which results in a Th2 profile, reduces the efficacy of DNA vaccines that are designed to induce antiviral CD8+ T cell responses.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS Vaccines / genetics
  • AIDS Vaccines / pharmacology*
  • Animals
  • Antigens, Protozoan / administration & dosage
  • CD8-Positive T-Lymphocytes / immunology
  • Genes, gag
  • HIV-1 / genetics
  • HIV-1 / immunology
  • Immune Tolerance
  • Immunity, Cellular
  • In Vitro Techniques
  • Leishmania major* / immunology
  • Leishmaniasis, Cutaneous / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Vaccines, DNA / genetics
  • Vaccines, DNA / pharmacology

Substances

  • AIDS Vaccines
  • Antigens, Protozoan
  • Vaccines, DNA